InsidersTradesSigma
Isofol Medical AB (publ) Stock: price and management transactions · Finland · FIN-FSA
Follow the Isofol Medical AB (publ) stock price and the full insider trade history of the company, a listed equity based in Finland. Shares trade on FI FI, under the authority of FIN-FSA. Operating in the Health Care sector, Isofol Medical AB (publ) has logged 1 public disclosures. Market capitalisation: €259.6m. The latest transaction was disclosed on 15 June 2026 (Purchase). Among the most active insiders: Petter Segelman Lindqvist. All data is openly available.
1
Insider Decl.
0
Thresholds
€8,441
1 ops.
Buy Volume
·
0 ops.
Sell Volume
30Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 15 June 2026
Declarations1 total
1,000,000 shares@ SEK 0.0923100.0% of flowTeckningsoptionFI:csv-91908161023c21b62fee
Ideal exit: 12 Mar 2027 (T+270)
1 of 1 declaration
About Isofol Medical AB (publ)
Isofol Medical AB (publ) is a Swedish pharmaceutical company focused on developing treatments for cancer. It is listed on the Stockholm Stock Exchange (XSTO).